Chest
Volume 120, Issue 1, July 2001, Pages 115-119
Journal home page for Chest

Clinical Investigations
Pulmonary Embolism
Steady-State End-Tidal Alveolar Dead Space Fraction and D-Dimer: Bedside Tests To Exclude Pulmonary Embolism

https://doi.org/10.1378/chest.120.1.115Get rights and content

Study objective

Less than 35% of patients suspectedof having pulmonary embolism (PE) actually have PE. Safe bedsidemethods to exclude PE could save health-care resources and improveaccess to diagnostic testing for suspected PE. In patients withsuspected PE, we sought to determine the sensitivity, specificity, andnegative predictive value of (1) a steady-state end-tidal alveolar deadspace fraction (AVDSf) of < 0.15, (2) a negative D-dimer result, and(3) the combination of a steady-state end-tidal AVDSf of < 0.15 and anegative D-dimer result.

Study design

Prospectivecohort study.

Setting

Tertiary-care center in Ottawa, Ontario, Canada.

Patients

Consecutiveinpatients, outpatients, and emergency department patients withsuspected PE referred to the Departments of Nuclear Medicine or Radiology for investigation of suspected PE.

Interventionsand measurements

All study patients had D-Dimer and alveolardead space measurements prior to determining outcome (PE or no PE) withventilation/perfusion scans and/or noninvasive leg vein imaging and/orpulmonary angiography.

Results

Two hundred forty-sixeligible and consenting patients underwent diagnostic imaging thatexcluded PE in 163 patients, diagnosed PE in 49 patients, and wasindeterminant in 34 patients. A negative D-dimer result excluded PEwith a sensitivity of 83.0% (95% confidence interval [CI], 69.2 to92.4%), a negative predictive value of 91.2% (95% CI, 83.4 to96.1%), and a specificity of 57.6%. A steady-state end-tidal AVDSf of< 0.15 excluded PE with a sensitivity of 79.5% (95% CI, 63.5 to90.7%), a negative predictive value of 90.7% (95% CI, 82.5 to95.9%), and a specificity of 70.3%. The combination of a negative D-dimer result and a steady-state end-tidal AVDSf of < 0.15 excluded PE with a sensitivity of 97.8% (95% CI, 88.5 to 99.9%), a negativepredictive value of 98.0% (95% CI, 89.4 to 99.9%), and a specificityof 38.0%.

Conclusion

This simple combination ofbedside tests may safely rule out PE without further diagnostic testingin large numbers of patients with suspected PE.

Section snippets

Patients

All inpatients and outpatients at the Ottawa Hospital - General Campus suspected of having PE and referred for a ventilation/perfusion ( V˙/ Q˙) scan or pulmonary angiogram from January 1996 to August 1998 were approached for consent to participate in the study. Patients were excluded from the study if they (1) were < 18 years of age, (2) were unable to give informed consent, (3) had a contraindication to pulmonary angiography, (4) were receiving mechanical ventilation, or (5) were

Results

We approached 293 patients, of whom 282 were eligible for participation in the study. Of these 282 patients, 246 consented. Of the 246 consenting patients, 49 patients (19.9%) had PE, 163 patients (66.3%) did not have PE, and 34 patients (13.8%) could not be classified with “gold standard” outcome measures (Table 1). Female patients were less likely to have PE. Patients with PE were significantly older (mean age, 58.9 years) than patients without PE (mean age, 50.6 years). More than 94% of our

Discussion

In this study, we have demonstrated that a negative D-dimer result and a steady-state end-tidal AVDSf of < 0.15 is a potentially safe method for excluding PE in patients with suspected PE. These bedside methods are simple, noninvasive, and inexpensive. Since both the D-dimer measurement and the steady-state end-tidal alveolar dead space measurement require minimal expertise and inexpensive equipment, these tests could be made available in all hospitals. The negative predictive value of this

References (8)

  • FA Anderson et al.

    A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism

    Arch Intern Med

    (1991)
  • JL Carson et al.

    The clinical course of pulmonary embolism

    N Engl J Med

    (1992)
  • PIOPED Investigators

    Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis study (PIOPED)

    JAMA

    (1990)
  • JA Kline et al.

    Use of the alveolar dead space fraction (Vd/Vt) and plasma D-dimers to exclude acute pulmonary embolism in ambulatory patients

    Acad Emerg Med

    (1997)
There are more references available in the full text version of this article.

Cited by (61)

  • Pulmonary embolism in Bradford, UK: Role of end-tidal CO<inf>2</inf> as a screening tool

    2014, Clinical Medicine, Journal of the Royal College of Physicians of London
  • Capnography as a diagnostic tool for pulmonary embolism: A meta-analysis

    2013, Annals of Emergency Medicine
    Citation Excerpt :

    The median age of included patients ranged from 38 to 70 years, and there was variation in patient selection (inpatients and outpatients) and consecutiveness. The prevalence of pulmonary embolism ranged from 5% to 69%, and D-dimer assay sensitivities ranged from 83%27 to 100%17; specificities, from 22%30 to 57%.27 Expired CO2 was measured with different types of meters (even self-modified devices) using mainstream or sidestream flow.

  • Cardiopulmonary exercise test in patients with subacute pulmonary emboli

    2012, Heart and Lung: Journal of Acute and Critical Care
    Citation Excerpt :

    A possible explanation for the increased incidence of men in the PE group was a higher prevalence of heart failure in men (50.9% vs 25.5%; P = .006), which is a known risk factor for PE. Respiratory dead space estimation has been suggested to diagnose PE and can be calculated using several equations.6,8,20 The ventilatory equivalent for CO2 (VE/VCO2) is a noninvasive method for estimating increased dead space.

View all citing articles on Scopus

This study was conducted at the Ottawa Hospital - General Campus.

Financial support was provided by the Ottawa General Hospital

Research Fund and the Clinical Trials and Research Unit of the Division of Hematology, Ottawa Hospital- General Campus.

Dr. Rodger was the recipient of the Thrombosis Interest Group of Canada Research Fellowship. Dr. Wells was the recipient of a Research Scholarship from the Heart and Stroke Foundation of Canada.

View full text